Trade Mark Journal No.2025/051 19 December 2025

UK00004308175 10 December 2025 (5)

STRYZACTA

International priority date claimed: 11 June 2025 (United States of America) (99228661)

Class 5: Pharmaceutical preparations for the treatment and prevention of oncological, hematological, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; diagnostic radiopharmaceutical preparations.

RayzeBio, Inc.

Representative: Sipara Limited